Fairvalue-Calculator Fairvalue-Calculator
EN DE

S.C. Ropharma S.A (RPH) Fair Value & Analysis

Healthcare · RO · Market cap 102M RON

Price0.2000 RON
Fair Value0.9400 RON
Upside+370.0%
Quality93/100
Evidence: Low Range 0.5500 RON – 1.70 RON

Fair value as of: Jun 24, 2026

Analysis

S.C. Ropharma S.A (RPH) currently trades at 0.2000 RON, while our model-based Fair Value estimate is 0.9400 RON — implying the stock looks roughly 370.0% undervalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

S.C. Ropharma S.A. operates a chain of pharmacies in Romania. The company distributes over-the-counter medications, food supplements, cosmetics, perfumes, medical devices, dermato-cosmetics, para pharmaceuticals, and other medicines through pharmaceutical warehouses. It also offers cardiovascular, dermatological, digestive, ophthalmological, osteoarticular, respiratory, urogenital, and diabetes medicines. In addition, the company provides supplements for immunity, antioxidants, vitamins and mineral medicines, and food and supplements for children, pregnancy, and breastfeeding medicines; and cosmetics for children, diapers, napkins, and protection against insects. Further, it offers body, hair, and skin care products; oral hygiene, solar protection, hand and foot care, and anti-insect products. Additionally, the company provides fertility, condoms, pregnancy and ovulation tests, and reproductive tonics; and medical equipment, protective glasses, and waterproof plasters. The company w…

Open the full interactive analysis →

Similar stocks

JD Health International Inc (JDHIF) +404% Alibaba Health Information Technology Limited (ALBBY) -19% Raia Drogasil S.A (RADL3) -8% Yifeng Pharmacy Chain Co (603939) +5% Clicks Group (CLCGY) +23% Sugi Holdings (SGIPF) +295%

Frequently asked questions

Is S.C. Ropharma S.A (RPH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 0.9400 RON versus a price of 0.2000 RON — about +370% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RPH?
Our 21-model fair value for S.C. Ropharma S.A is 0.9400 RON (as of Jun 24, 2026), built from audited fundamentals. The current price is 0.2000 RON.
What is the quality score of RPH?
S.C. Ropharma S.A has a Quality Score of 93/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.